Go Pro
NYSE:CC

Chemours (CC) Stock Price, News & Analysis

Chemours logo
$15.75 +0.64 (+4.21%)
Closing price 03:59 PM Eastern
Extended Trading
$15.51 -0.24 (-1.49%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Chemours Stock (NYSE:CC)

Advanced

Key Stats

Today's Range
$15.34
$16.23
50-Day Range
$14.65
$23.16
52-Week Range
$10.44
$28.67
Volume
2.87 million shs
Average Volume
2.72 million shs
Market Capitalization
$2.37 billion
P/E Ratio
N/A
Dividend Yield
2.22%
Price Target
$22.50
Consensus Rating
Moderate Buy

Company Overview

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments. The Titanium Technologies segment produces and markets titanium dioxide, a critical ingredient in paints, coatings, plastics, paper and other consumer goods. The Thermal & Specialized Solutions segment supplies refrigerants, cooling and heating products, as well as industrial chemicals used in mining, metals processing and refrigeration. The Advanced Performance Materials segment offers specialty fluoropolymers and fluorinated surfactants that serve high-technology applications such as semiconductor manufacturing, automotive components and electronics.

With manufacturing facilities and research centers across North America, Europe, Asia Pacific and Latin America, Chemours serves a diverse international customer base spanning automotive, construction, electronics, packaging and general industrial markets. At its inception, Mark P. Vergnano was appointed chief executive officer and has overseen the company’s strategic growth and operational integration. Under its leadership team, Chemours continues to invest in process improvements, digitalization and sustainable product development to meet evolving regulatory and customer demands worldwide.

AI Generated. May Contain Errors.

Chemours Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
87th Percentile Overall Score

CC MarketRank™: 

Chemours scored higher than 87% of companies evaluated by MarketBeat, and ranked 58th out of 228 stocks in the materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Chemours has received a consensus rating of Moderate Buy. The company's average rating score is 2.58, and is based on 1 strong buy rating, 6 buy ratings, 4 hold ratings, and 1 sell rating.

  • Upside Potential

    Chemours has a consensus price target of $22.50, representing about 42.9% upside from its current price of $15.75.

  • Amount of Analyst Coverage

    Chemours has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Chemours' stock forecast and price target.
  • Earnings Growth

    Earnings for Chemours are expected to grow by 89.83% in the coming year, from $1.18 to $2.24 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Chemours is -8.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Chemours is -8.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    7.84% of the float of Chemours has been sold short.
  • Short Interest Ratio / Days to Cover

    Chemours has a short interest ratio ("days to cover") of 4.57.
  • Change versus previous month

    Short interest in Chemours has recently decreased by 7.28%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Chemours pays a meaningful dividend of 2.32%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Chemours does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Chemours will have a dividend payout ratio of 15.63% next year. This indicates that Chemours will be able to sustain or increase its dividend.

  • Read more about Chemours' dividend.
  • News Sentiment

    Chemours has a news sentiment score of 0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Materials companies.
  • News Coverage This Week

    MarketBeat has tracked 24 news articles for Chemours this week, compared to 5 articles on an average week.
  • Search Interest

    22 people have searched for CC on MarketBeat in the last 30 days. This is an increase of 144% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Chemours to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Chemours insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.85% of the stock of Chemours is held by insiders.

  • Percentage Held by Institutions

    76.26% of the stock of Chemours is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Chemours' insider trading history.
Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CC Stock News Headlines

Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race.tc pixel
The Chemours Company (CC) Q2 2026 Earnings Call Transcript
Why Chemours Plunged on Wednesday
Chemours (CC) Q2 2026
Chemours: Q2 Earnings Snapshot
See More Headlines

CC Stock Analysis - Frequently Asked Questions

Chemours' stock was trading at $11.76 at the start of the year. Since then, CC shares have increased by 33.9% and is now trading at $15.7460.

The Chemours Company (NYSE:CC) posted its quarterly earnings data on Tuesday, August, 4th. The specialty chemicals company reported $0.42 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.49 by $0.07. Chemours's revenue for the quarter was down 1.5% compared to the same quarter last year.
Read the conference call transcript
.

Chemours' top institutional investors include BlackRock Inc. (15.48%), Bank of New York Mellon Corp (1.08%), Old West Investment Management LLC (0.23%) and Deutsche Bank AG (0.11%). Insiders that own company stock include Denise Dignam, Damian Gumpel, Shane Hostetter, Diane I Picho and Alvenia Scarborough.
View institutional ownership trends
.

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Chemours investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), AT&T (T), Tesla (TSLA), Chevron (CVX) and JPMorgan Chase & Co. (JPM).

Company Calendar

Ex-Dividend for 6/16 Dividend
5/15/2026
Record date for 6/16 Dividend
5/17/2026
Dividend Payable
6/16/2026
Last Earnings
8/04/2026
Today
8/07/2026
Record date for 9/15 Dividend
8/14/2026
Ex-Dividend for 9/15 Dividend
8/14/2026
Dividend Payable
9/15/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Materials
Industry
Chemicals
Sub-Industry
Diversified Chemicals
Current Symbol
NYSE:CC
CIK
1627223
Fax
N/A
Employees
5,700
Year Founded
2015

Price Target and Rating

High Price Target
$30.00
Low Price Target
$17.00
Potential Upside/Downside
+42.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.58
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.91)
Trailing P/E Ratio
N/A
Forward P/E Ratio
13.34
P/E Growth
N/A
Net Income
-$386 million
Net Margins
-5.00%
Pretax Margin
-0.90%
Return on Equity
60.64%
Return on Assets
1.48%

Debt

Debt-to-Equity Ratio
18.98
Current Ratio
1.66
Quick Ratio
0.87

Sales & Book Value

Annual Sales
$5.81 billion
Price / Sales
0.41
Cash Flow
$3.44 per share
Price / Cash Flow
4.58
Book Value
($0.32) per share
Price / Book
-49.21

Miscellaneous

Outstanding Shares
150,500,000
Free Float
149,100,000
Market Cap
$2.37 billion
Optionable
Optionable
Beta
1.43

Social Links

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:CC) was last updated on 8/7/2026 by MarketBeat.com Staff.
From Our Partners